Prosecution Insights
Last updated: August 17, 2026

New York University

41 pending office actions • 29 art units • 39 examiners • 0 of 41 (0%) have an AI response strategy ready • 30 patents granted in the last 365 days

Portfolio Summary

41
Total Pending OAs
27
Non-Final OAs
13
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 15 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

8
Overdue
0
Due this week
6
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 15 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (8)Due ≤ 30 days (6)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

22
Hard (54%)
14
Medium (34%)
5
Easy (12%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other12 (29%)
§103 only10 (24%)
§102 only3 (7%)
§112 only4 (10%)
Double-patenting only1 (2%)
Double-patenting + other1 (2%)
Multi-statute (no §101)10 (24%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

21
Life Sciences
51% of docket
0
Information Tech
0% of docket
2
Communications
5% of docket
2
Semiconductors
5% of docket
10
Mechanical / Eng
24% of docket
6
Business / Other
15% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

410 h
Manual time on pending OAs
82 h
Time saved (low, 20%)
144 h
Time saved (mid, 35%)
3.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HANNA, SAMUEL SALEEB 2 58.1% +36.6%
MYERS, CARLA J 2 49.0% +46.6%
TOKARCZYK, CHRISTOPHER B 1 43.3% +23.3%
NEWTON, CHAD A 1 38.0% +25.0%
FULLER, RODNEY EVAN 1 83.8% +7.9%
KHATTAR, RAJESH 1 36.2% +34.8%
SANGHERA, JAS A 1 94.6% +4.9%
DHARIA, PRABODH M 1 85.5% +5.5%
CORNET, JEAN P 1 42.1% +47.5%
GURMU, MULUEMEBET 1 80.1% +17.7%

Quick Wins (3)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18923344 SYSTEM, METHOD AND COMPUTER-ACCESSIBLE MEDIUM FOR DETERMINING ROTATIONAL INVARIANTS OF CUMULANT EXPANSION FROM ONE OR MORE ACQUISITIONS WHICH CAN BE MINIMAL FULLER, RODNEY EVAN
18884550 HUMAN COLOR DISCRIMINATION FOR MEMORY-EFFICIENT ENCODING IN EXTENDED REALITY DHARIA, PRABODH M
18646234 SYSTEMS, METHODS, AND COMPUTER-ACCESSIBLE MEDIUM FOR PROVIDING HUMAN-MODEL ALIGNMENT USING METADATA AND ARTIFACTS, PATIENT INFORMATION, OR SYNTHETIC DATA GURMU, MULUEMEBET

Hard Cases (22)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18251384 ENHANCEMENT OF PREDICTABLE AND TEMPLATE-FREE GENE EDITING BY THE ASSOCIATION OF CAS WITH DNA POLYMERASE TATGE, LEXUS MARC 37d overdue
18186698 TARGETING SUCNR1 TO REDUCE NEUROINFLAMMATION RODRIGUEZ, RAYNA B 37d overdue
18247155 JOINT DISTRACTION DEVICE HANNA, SAMUEL SALEEB 10d overdue
18575905 SYSTEMS, METHODS AND COMPUTER-ACCESSIBLE MEDIUM FACILITATING DEPLOYMENT OF ANTIDEPRESSANTS AND OTHER PRESCRIPTION DRUGS HUYNH, EMILY 8d
17637427 TARGETING SLC38A2 IN PANCREATIC CANCER ANGELL, JON E 9d
17642471 HIGH-GAIN AMORPHOUS SELENIUM PHOTOMULTIPLIER YECHURI, SITARAMARAO S 22d
17626598 METHODS AND COMPOSITIONS FOR SCALABLE POOLED RNA SCREENS WITH SINGLE CELL CHROMATIN ACCESSIBILITY PROFILING YOUNG, BRIAN ELLIS 30d
18388088 THERAPEUTIC STRATEGIES TO TARGET TUMORS WITH ALTERATIONS IN LKB1 PATHWAY CASH, KAILEY ELIZABETH 83d

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18247155 JOINT DISTRACTION DEVICE HANNA, SAMUEL SALEEB 10d overdue
19292081 SYSTEMS, APPARATUS, METHODS AND COMPUTER-ACCESSIBLE MEDIUM FOR PROVIDING HEALTH SYSTEM SCALE LANGUAGE MODELS WHICH CAN INCLUDE CLINICAL PREDICTION ENGINES TOKARCZYK, CHRISTOPHER B
18877884 SEMI-RADIOLUCENT PATIENT-SPECIFIC 3D-PRINTED LATTICE TITANIUM PLATE HANNA, SAMUEL SALEEB
18940457 SYSTEM AND METHOD FOR ASSESSING INTRACRANIAL ANEURYSMS NEWTON, CHAD A
18908152 SYSTEM, METHOD AND COMPUTER-ACCESSIBLE MEDIUM FOR INVESTIGATING ALGORITHMIC HIRING BIAS KHATTAR, RAJESH
18835261 USE OF RETINOIDS FOR TREATMENT OF ATRIAL FIBRILLATION CORNET, JEAN P
18646234 SYSTEMS, METHODS, AND COMPUTER-ACCESSIBLE MEDIUM FOR PROVIDING HUMAN-MODEL ALIGNMENT USING METADATA AND ARTIFACTS, PATIENT INFORMATION, OR SYNTHETIC DATA GURMU, MULUEMEBET
18264314 METHODS AND BIOMARKERS IN CANCER MYERS, CARLA J

Top Art Units

Art UnitApps
3791 3
3775 2
1654 2
1682 2
1637 2
3681 1
3684 1
2852 1
2629 1
1631 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19292081 SYSTEMS, APPARATUS, METHODS AND COMPUTER-ACCESSIBLE MEDIUM FOR PROVIDING HEALTH SYSTEM SCALE LANGUAGE MODELS WHICH CAN INCLUDE CLINICAL PREDICTION ENGINES TOKARCZYK, CHRISTOPHER B §101§102§103 Non-Final OA Pending Aug 06, 2025
18877884 SEMI-RADIOLUCENT PATIENT-SPECIFIC 3D-PRINTED LATTICE TITANIUM PLATE HANNA, SAMUEL SALEEB 3775 §102 Non-Final OA Pending Dec 20, 2024
18940457 SYSTEM AND METHOD FOR ASSESSING INTRACRANIAL ANEURYSMS NEWTON, CHAD A 3681 §101§103 Final Rejection Pending Nov 07, 2024
18923344 SYSTEM, METHOD AND COMPUTER-ACCESSIBLE MEDIUM FOR DETERMINING ROTATIONAL INVARIANTS OF CUMULANT EXPANSION FROM ONE OR MORE ACQUISITIONS WHICH CAN BE MINIMAL FULLER, RODNEY EVAN §102 Non-Final OA Pending Oct 22, 2024
18908152 SYSTEM, METHOD AND COMPUTER-ACCESSIBLE MEDIUM FOR INVESTIGATING ALGORITHMIC HIRING BIAS KHATTAR, RAJESH 3684 §101§103 Non-Final OA Pending Oct 07, 2024
18848241 DEVICES AND METHODS FOR RAPID BIOSENSING SANGHERA, JAS A 2852 §102§103§112 Non-Final OA Pending Sep 18, 2024
18884550 HUMAN COLOR DISCRIMINATION FOR MEMORY-EFFICIENT ENCODING IN EXTENDED REALITY DHARIA, PRABODH M 2629 §103 Non-Final OA Pending Sep 13, 2024
18835261 USE OF RETINOIDS FOR TREATMENT OF ATRIAL FIBRILLATION CORNET, JEAN P §112 Non-Final OA Pending Aug 01, 2024
18646234 SYSTEMS, METHODS, AND COMPUTER-ACCESSIBLE MEDIUM FOR PROVIDING HUMAN-MODEL ALIGNMENT USING METADATA AND ARTIFACTS, PATIENT INFORMATION, OR SYNTHETIC DATA GURMU, MULUEMEBET §103 Non-Final OA Pending Apr 25, 2024
18294021 NORA INHIBITORS AND METHODS OF USE COFFA, SERGIO §102 Non-Final OA Pending Jan 31, 2024
18580093 AUF1 COMBINATION THERAPIES FOR TREATMENT OF MUSCLE DEGENERATIVE DISEASE PRONZATI, GINA 1631 §103 Non-Final OA Pending Jan 17, 2024
18575905 SYSTEMS, METHODS AND COMPUTER-ACCESSIBLE MEDIUM FACILITATING DEPLOYMENT OF ANTIDEPRESSANTS AND OTHER PRESCRIPTION DRUGS HUYNH, EMILY 3683 §101§112 Non-Final OA 8d Pending Jan 02, 2024
18508879 Smart Wearable IOT Device for Health Tracking, Contact Tracing and Prediction of Health Deterioration HUSSAINI, ATTIYA SAYYADA 3792 §102§103§112 Non-Final OA Pending Nov 14, 2023
18388088 THERAPEUTIC STRATEGIES TO TARGET TUMORS WITH ALTERATIONS IN LKB1 PATHWAY CASH, KAILEY ELIZABETH 1683 §101§103§112DP Non-Final OA 83d Pending Nov 08, 2023
18384122 Apparatus And Method For Data Augmentation HUTCHESON, CODY DOUGLAS 2659 §101§112 Non-Final OA Pending Oct 26, 2023
18487767 COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING AUTOIMMUNE INDUCED CARDIAC LONG QT SYNDROME WEIDNER, ADAM M 1675 DP Final Rejection 26d overdue Pending Oct 16, 2023
18467202 SYSTEM AND METHOD FOR AUTONOMOUS CHARGING OMAR, AHMED H §102§103 Non-Final OA Pending Sep 14, 2023
18280186 APPLICATION OF APOPTOSIS INHIBITOR 5 (API5) FOR EPITHELIAL RESTITUTION HA, JULIE 1654 §101§102§103§112 Non-Final OA Pending Sep 01, 2023
18460519 FLUORINATED FIBERS FOR MULTIMODAL 1H AND 19F MRI, ULTRASOUND, FLUORESCENCE DETECTION AND CONFORMATIONAL AND TEMPERATURE DETECTION BY 19F MRS VARADARAJ, ARCHANA 1658 §102§103§112DP Non-Final OA Pending Sep 01, 2023
18264314 METHODS AND BIOMARKERS IN CANCER MYERS, CARLA J 1682 §101§103§112Other Non-Final OA Pending Aug 04, 2023
18259637 CROSSLINKED HELIX DIMER MIMICS OF SOS AND METHODS OF USING SAME GARYU, LIANKO G 1654 §101§102§103§112DPOther Non-Final OA Pending Jun 28, 2023
18257609 WEARABLE INERTIAL SENSOR SYSTEM AND METHODS YOON, CHANEL J 3791 §101§103§112 Non-Final OA Pending Jun 15, 2023
18041627 Methods and Compositions for Inhibiting Viral Infection OH, TAYLOR V 1625 §102§103§112 Non-Final OA Pending Jun 02, 2023
18252285 NPC1 MONOBODIES AND MONOBODY CONJUGATES THEREOF PETERS, ALEC JON 1641 §103 Non-Final OA Pending May 09, 2023
18251384 ENHANCEMENT OF PREDICTABLE AND TEMPLATE-FREE GENE EDITING BY THE ASSOCIATION OF CAS WITH DNA POLYMERASE TATGE, LEXUS MARC 1637 §101§102§103§112 Non-Final OA 37d overdue Pending May 01, 2023
18303421 IL-17 RECEPTOR MODULATOR SCREENING SYSTEM ABBAS, SYED JARAR 1656 §103§112 Non-Final OA Pending Apr 19, 2023
18247155 JOINT DISTRACTION DEVICE HANNA, SAMUEL SALEEB 3775 §102§103§112 Final Rejection 10d overdue Pending Mar 29, 2023
18186698 TARGETING SUCNR1 TO REDUCE NEUROINFLAMMATION RODRIGUEZ, RAYNA B 1628 §102§103§112 Non-Final OA 37d overdue Pending Mar 20, 2023
18000212 HIGH DENSITY EEG SYSTEM FOR PRECISION PSYCHIATRY EPPERT, LUCY CLARE 3791 §103 Final Rejection Pending Nov 29, 2022
17816152 Tumor-on-a-chip MYERS, CARLA J 1682 §112 Final Rejection Pending Jul 29, 2022
17789047 THE COMBINATION OF CYCLIN DEPENDENT KINASE 7 INHIBITOR AND IMMUNOTHERAPY FOR TREATMENT OF CANCER SCHMIDT, IZABELA MARIA 1621 §103Other Final Rejection 30d Pending Jun 24, 2022
17642471 HIGH-GAIN AMORPHOUS SELENIUM PHOTOMULTIPLIER YECHURI, SITARAMARAO S 2893 §103§112 Final Rejection 22d Pending Mar 11, 2022
17637427 TARGETING SLC38A2 IN PANCREATIC CANCER ANGELL, JON E 1637 §102§103 Non-Final OA 9d Pending Feb 22, 2022
17592169 BIOMIMETIC TISSUE AND METHOD OF USE THEREOF ARNOLD, ERNST V 1613 §103 Non-Final OA 36d overdue Pending Feb 03, 2022
17626598 METHODS AND COMPOSITIONS FOR SCALABLE POOLED RNA SCREENS WITH SINGLE CELL CHROMATIN ACCESSIBILITY PROFILING YOUNG, BRIAN ELLIS 1684 §103§112 Final Rejection 30d Pending Jan 12, 2022
17625326 TUMOR IMMUNOTHERAPY USING SINDBIS VIRAL VECTORS AND AGONIST MONOCLONAL ANTIBODIES HALVORSON, MARK 1646 §103 Final Rejection 43d overdue Pending Jan 06, 2022
17608103 METHODS AND COMPOSITIONS FOR SENSITIZING CANCER CELLS TO DRUG-INDUCED APOPTOSIS BAKSHI, PANCHAM 1623 §112 Final Rejection 72d overdue Pending Nov 01, 2021
17445915 SYSTEM AND METHOD FOR CONCUSSIVE IMPACT MONITORING ORTEGA, MARTIN NATHAN 3791 §103 Final Rejection Pending Aug 25, 2021
17371613 GRAPHITIC CARBON NITRIDE MATERIALS AND METHODS OF MAKING AND USE THEREOF ALEJANDRO, RAYMOND 1752 §103 Final Rejection 28d Pending Jul 09, 2021
17152463 ADENO-ASSOCIATED VIRAL VECTOR, COMPOSITIONS, METHODS OF PROMOTING MUSCLE REGENERATION, AND TREATMENT METHODS NICOL, ALEXANDER W 1634 §112 Final Rejection 72d overdue Pending Jan 19, 2021
16960530 SYSTEM AND METHOD FOR BLOOD GLUCOSE MONITORING USING MAGNETIC RESONANCE SPECTROSCOPY ROBINSON, NICHOLAS A 3798 §101§102§103§112 Non-Final OA Pending Jul 07, 2020

Managing New York University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month